News
September 11, 2007 - CellCyte Genetics Corp. has entered into a collaborative research agreement with physician scientists at the Cleveland Clinic Foundation to investigate the presence and regulation of heart receptors involved in stem cell trafficking in normal and diseased human hearts, using CellCyte's proprietary compounds, with the goal of increasing volumes of stem cells delivered.
September 10, 2007
Feature | Maureen Leahy-Patano
When it comes to diagnosing disease, image is everything. It is difficult to treat what you can’t see. That’s especially true in the cardiac cath lab where cardiologists performing procedures ranging from simple diagnostic tests to more complex interventional maneuvers rely on imaging technology to guide their course.
September 10, 2007News
September 10, 2007 - Signalife launched the sales of its new, FDA-approved, ambulatory 12-lead ECG cardiovascular ...
September 09, 2007Sponsored Content
Feature | Information Technology
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
March 21, 2024
Feature | Melissa Allen
According to the Centers for Disease Control and Prevention, more than 70 million Americans currently live with ...
September 09, 2007News
September 10, 2007 - Four analyses of three-year follow-up data that were presented at the ESC Congress 2007 showed that ...
September 09, 2007News
September 7, 2007 - Gary Ansel, M.D., Riverside Methodist Hospital, successfully implanted the GORE VIABAHN ...
September 09, 2007Sponsored Content
Feature | Cardiac Imaging
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
March 05, 2024
Feature
iffering approaches for the treatment of coronary bifurcation and ostial lesions (CBOL) continue to feed the debate over which stent designs and stenting techniques are most effective.
September 09, 2007News
September 6, 2007 — ProSolv CardioVascular, a FUJIFILM company (ProSolv), announced at the 12th Annual Scientific ...
September 09, 2007Feature | Cristen C. Bolan
Just when drug-eluting stents (DES) were going to revolutionize interventional cardiology, new reports that DES may be associated with increased risk of late-stent thrombosis have many physicians putting the brakes on DES use. Despite this significant bump in the road, stent manufacturers are forging ahead with clinical trials on novel systems and on plans to roll out new DES platforms in 2008.
September 09, 2007Sponsored Content
Blog
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
December 11, 2023
Technology
Combining all features of the ACIST CMS and Voyager systems onto one platform, the ACIST CVi Contrast Delivery System ...
September 06, 2007
Technology
Sony Electronics recently introduced its LMD-2450MD 24-inch monitor, which offers 10-bit signal processing and Sony ...
September 06, 2007
Technology
Possis Medical Inc. will feature the newest advancements in its “Complete Solution for Thrombus,” including the AngioJet Ultra Thrombectomy System, AngioJet Spiroflex and Spiroflex VG catheters and its Fetch Aspiration Catheter.
September 06, 2007Sponsored Content
Case Study | Hemodynamic Monitoring Systems
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
November 14, 2023
Technology
Siemens Automation and Drives (A&D) has added a 1MP color display to its portfolio of medical monitors. The SCD 19110 ...
September 05, 2007
Technology
Cordis Endovascular announced, at the 61st Annual Meeting of the Society for Vascular Surgery, the worldwide launch of ...
September 05, 2007News
September 6, 2007 - Cleveland Clinic will host its fifth annual Medical Innovation Summit, an international gathering of healthcare, business and media leaders to examine trends in medical innovation and cardiovascular technologies, Oct. 1-3.
September 05, 2007© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now